Azura Ophthalmics
AcquiredTel Aviv, Israel · $36.0M raised
- Headquarters
- Tel Aviv
- Employees
- 1–10
- Business Model
- B2B
- Website
- azuraophthalmics.com
- Total Funding
- $36.0M
- Last Round
- $20.0M Series COct 2020
- Rounds
- 3
About
Clinical-stage biotech developing ophthalmic keratolytic therapies targeting meibomian gland dysfunction and ocular surface diseases.
Summary
Azura Ophthalmics is a Biotech company based in Tel Aviv, Israel. It has raised $36.0M in total across 3 rounds, most recently a $20.0M Series C round in Oct 2020. Investors include OrbiMed, Brandon Capital Partners and TPG Biotechnology Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2020
Sign up to see all 3 rounds
Seed through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/azura-ophthalmics"><img src="https://indexed.vc/api/badge/company/azura-ophthalmics" alt="Azura Ophthalmics on Indexed.vc" width="260" height="76" /></a>